UroGen Pharma Ltd. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 51.0M | 37.8M | 27.5M | 24.2M | 20.3M | 24.6M | 25.2M | 21.8M |
| Cost of Goods Sold | 4.1M | 3.3M | 3.3M | 3.5M | 2.3M | 2.5M | 2.5M | 2.2M |
| Gross Profit | 46.8M | 34.5M | 24.2M | 20.7M | 17.9M | 22.1M | 22.8M | 19.6M |
| R&D Expenses | 15.6M | 14.3M | 14.0M | 18.9M | 19.9M | 14.9M | 11.4M | 15.4M |
| Operating Expenses | 67.1M | 53.7M | 51.6M | 62.1M | 54.8M | 49.8M | 40.3M | 45.5M |
| Operating Income | -20.3M | -19.1M | -27.4M | -41.4M | -36.9M | -27.7M | -17.5M | -25.8M |
| Other Income / Gains | -8.1M | -7.5M | -7.0M | -7.5M | -6.5M | -7.2M | -6.0M | -7.5M |
| Net Income | -23.6M | -26.4M | -33.3M | -49.9M | -43.8M | -37.5M | -23.7M | -33.4M |
| EPS (Diluted) | -0.47 | -0.54 | -0.69 | -1.05 | -0.92 | -0.80 | -0.55 | -0.91 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.919 | 0.913 | 0.881 | 0.853 | 0.885 | 0.899 | 0.903 | 0.898 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 51.5M | 39.3M | 37.6M | 43.2M | 35.0M | 0 | 28.9M | 30.1M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 34.9M | 0 | 0 |
| Cost And Expenses | 71.2M | 57.0M | 54.9M | 65.7M | 57.2M | 52.2M | 42.7M | 47.7M |
| Interest Income | 931K | 908K | 1.2M | 1.7M | 2.2M | 2.8M | 2.8M | 1.7M |
| Interest Expense | 8.7M | 13.0M | 8.0M | 8.8M | 4.1M | 3.9M | 2.7M | 3.5M |
| Depreciation And Amortization | 652K | 679K | 639K | 596K | 497K | 68K | 266K | 263K |
| Ebitda | -19.0M | -22.2M | -25.8M | -48.8M | -38.9M | -26.5M | -14.7M | -29.6M |
| Ebitdaratio | -0.373 | -0.586 | -0.938 | -2.016 | -1.92 | -1.078 | -0.582 | -1.357 |
| Operating Income Ratio | -0.398 | -0.505 | -0.997 | -1.712 | -1.823 | -1.126 | -0.696 | -1.183 |
| Income Before Tax | -28.3M | -26.6M | -34.4M | -48.9M | -43.5M | -34.9M | -23.6M | -33.4M |
| Income Before Tax Ratio | -0.556 | -0.704 | -1.252 | -2.02 | -2.145 | -1.419 | -0.936 | -1.527 |
| Income Tax Expense | -4.8M | -275K | -1.1M | 1.0M | 392K | 2.6M | 91K | 38K |
| Net Income Ratio | -0.463 | -0.697 | -1.213 | -2.062 | -2.165 | -1.527 | -0.939 | -1.529 |
| Epsdiluted | -0.47 | -0.54 | -0.69 | -1.05 | -0.92 | -0.80 | -0.55 | -0.91 |
| Weighted Average Shs Out | 50.2M | 49.2M | 48.1M | 47.7M | 47.4M | 47.0M | 43.1M | 36.8M |
| Weighted Average Shs Out Dil | 50.2M | 49.2M | 48.1M | 47.7M | 47.4M | 47.0M | 43.1M | 36.8M |